Longitudinal study on the effects of growth-promoting and therapeutic antibiotics on the dynamics of chicken cloacal and litter microbiomes and resistomes.
16S rRNA gene amplicon sequencing
Antibiotic resistance genes
Antibiotic-resistant bacteria
Antimicrobial resistance
Broiler chickens
Growth-promoting antibiotics
HT-qPCR
Microbiome
Priority pathogens
Shotgun metagenomics
Journal
Microbiome
ISSN: 2049-2618
Titre abrégé: Microbiome
Pays: England
ID NLM: 101615147
Informations de publication
Date de publication:
28 08 2021
28 08 2021
Historique:
received:
07
01
2021
accepted:
20
07
2021
entrez:
29
8
2021
pubmed:
30
8
2021
medline:
14
9
2021
Statut:
epublish
Résumé
Therapeutic and growth-promoting antibiotics are frequently used in broiler production. Indirect evidence indicates that these practices are linked to the proliferation of antimicrobial resistance (AMR), the spread of antibiotic-resistant bacteria from food animals to humans, and the environment, but there is a lack of comprehensive experimental data supporting this. We investigated the effects of growth promotor (bacitracin) and therapeutic (enrofloxacin) antibiotic administration on AMR in broilers for the duration of a production cycle, using a holistic approach that integrated both culture-dependent and culture-independent methods. We specifically focused on pathogen-harboring families (Enterobacteriaceae, Enterococcaceae, and Staphylococcaceae). Antibiotic-resistant bacteria and antibiotic resistance genes were ubiquitous in chicken cloaca and litter regardless of antibiotic administration. Environment (cloaca vs. litter) and growth stage were the primary drivers of variation in the microbiomes and resistomes, with increased bacterial diversity and a general decrease in abundance of the pathogen-harboring families with age. Bacitracin-fed groups had higher levels of bacitracin resistance genes and of vancomycin-resistant Enterococcaceae (total Enterococcaceae counts were not higher). Although metagenomic analyses classified 28-76% of the Enterococcaceae as the commensal human pathogens E. faecalis and E. faecium, culture-based analysis suggested that approximately 98% of the vancomycin-resistant Enterococcaceae were avian and not human-associated, suggesting differences in the taxonomic profiles of the resistant and non-resistant strains. Enrofloxacin treatments had varying effects, but generally facilitated increased relative abundance of multidrug-resistant Enterobacteriaceae strains, which were primarily E. coli. Metagenomic approaches revealed a diverse array of Staphylococcus spp., but the opportunistic pathogen S. aureus and methicillin resistance genes were not detected in culture-based or metagenomic analyses. Camphylobacteriaceae were significantly more abundant in the cloacal samples, especially in enrofloxacin-treated chickens, where a metagenome-assembled C. jejuni genome harboring fluoroquinolone and β-lactam resistance genes was identified. Within a "farm-to-fork, one health" perspective, considering the evidence that bacitracin and enrofloxacin used in poultry production can select for resistance, we recommend their use be regulated. Furthermore, we suggest routine surveillance of ESBL E. coli, vancomycin-resistant E. faecalis and E. faecium, and fluoroquinolone-resistant C. jejuni strains considering their pathogenic nature and capacity to disseminate AMR to the environment. Video Abstract.
Sections du résumé
BACKGROUND
Therapeutic and growth-promoting antibiotics are frequently used in broiler production. Indirect evidence indicates that these practices are linked to the proliferation of antimicrobial resistance (AMR), the spread of antibiotic-resistant bacteria from food animals to humans, and the environment, but there is a lack of comprehensive experimental data supporting this. We investigated the effects of growth promotor (bacitracin) and therapeutic (enrofloxacin) antibiotic administration on AMR in broilers for the duration of a production cycle, using a holistic approach that integrated both culture-dependent and culture-independent methods. We specifically focused on pathogen-harboring families (Enterobacteriaceae, Enterococcaceae, and Staphylococcaceae).
RESULTS
Antibiotic-resistant bacteria and antibiotic resistance genes were ubiquitous in chicken cloaca and litter regardless of antibiotic administration. Environment (cloaca vs. litter) and growth stage were the primary drivers of variation in the microbiomes and resistomes, with increased bacterial diversity and a general decrease in abundance of the pathogen-harboring families with age. Bacitracin-fed groups had higher levels of bacitracin resistance genes and of vancomycin-resistant Enterococcaceae (total Enterococcaceae counts were not higher). Although metagenomic analyses classified 28-76% of the Enterococcaceae as the commensal human pathogens E. faecalis and E. faecium, culture-based analysis suggested that approximately 98% of the vancomycin-resistant Enterococcaceae were avian and not human-associated, suggesting differences in the taxonomic profiles of the resistant and non-resistant strains. Enrofloxacin treatments had varying effects, but generally facilitated increased relative abundance of multidrug-resistant Enterobacteriaceae strains, which were primarily E. coli. Metagenomic approaches revealed a diverse array of Staphylococcus spp., but the opportunistic pathogen S. aureus and methicillin resistance genes were not detected in culture-based or metagenomic analyses. Camphylobacteriaceae were significantly more abundant in the cloacal samples, especially in enrofloxacin-treated chickens, where a metagenome-assembled C. jejuni genome harboring fluoroquinolone and β-lactam resistance genes was identified.
CONCLUSIONS
Within a "farm-to-fork, one health" perspective, considering the evidence that bacitracin and enrofloxacin used in poultry production can select for resistance, we recommend their use be regulated. Furthermore, we suggest routine surveillance of ESBL E. coli, vancomycin-resistant E. faecalis and E. faecium, and fluoroquinolone-resistant C. jejuni strains considering their pathogenic nature and capacity to disseminate AMR to the environment. Video Abstract.
Identifiants
pubmed: 34454634
doi: 10.1186/s40168-021-01136-4
pii: 10.1186/s40168-021-01136-4
pmc: PMC8403378
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
178Informations de copyright
© 2021. The Author(s).
Références
Rev Sci Tech. 2012 Apr;31(1):145-88
pubmed: 22849274
BMC Vet Res. 2018 Mar 27;14(1):113
pubmed: 29587768
Antimicrob Resist Infect Control. 2019 May 22;8:80
pubmed: 31139363
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Microbiol. 2009 Feb;47(1):19-27
pubmed: 19229487
Bioinformatics. 2012 Dec 1;28(23):3150-2
pubmed: 23060610
Drug Resist Updat. 2000 Oct;3(5):303-311
pubmed: 11498398
Clin Microbiol Infect. 2016 Jan;22(1):12-21
pubmed: 26493844
Sci Rep. 2021 Feb 8;11(1):3290
pubmed: 33558560
Ann Clin Microbiol Antimicrob. 2013 Aug 28;12:22
pubmed: 23984642
Science. 2006 May 5;312(5774):741-4
pubmed: 16675700
Ann Clin Microbiol Antimicrob. 2012 Nov 27;11:31
pubmed: 23181410
PeerJ. 2019 Jul 26;7:e7359
pubmed: 31388474
Anim Nutr. 2018 Jun;4(2):170-178
pubmed: 30140756
J Antimicrob Chemother. 2013 Jul;68(7):1583-93
pubmed: 23460607
Microbiome. 2017 Nov 28;5(1):154
pubmed: 29179769
Methods Mol Biol. 2018;1783:149-169
pubmed: 29767361
Sci Rep. 2016 Oct 12;6:34895
pubmed: 27731342
Int J Med Microbiol. 2013 Aug;303(6-7):287-92
pubmed: 23499305
PeerJ. 2018 Nov 2;6:e5882
pubmed: 30405973
Antimicrob Agents Chemother. 2009 Aug;53(8):3357-64
pubmed: 19506058
Nat Commun. 2013;4:2151
pubmed: 23877117
Microbiome. 2018 Feb 01;6(1):23
pubmed: 29391044
PLoS Comput Biol. 2016 Jun 21;12(6):e1004957
pubmed: 27327495
J Clin Microbiol. 2002 Nov;40(11):3970-5
pubmed: 12409360
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Environ Sci Technol. 2014 Nov 18;48(22):13120-9
pubmed: 25338275
Epidemiol Infect. 1990 Aug;105(1):21-7
pubmed: 2200698
J Food Prot. 2007 Jun;70(6):1316-27
pubmed: 17612058
Genome Biol. 2014;15(12):550
pubmed: 25516281
BMC Vet Res. 2020 Jun 19;16(1):205
pubmed: 32560721
Environ Int. 2020 May;138:105667
pubmed: 32234679
Emerg Infect Dis. 2001 Jan-Feb;7(1):24-34
pubmed: 11266291
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Prev Vet Med. 1997 Jul;31(1-2):95-112
pubmed: 9234429
Microbiome. 2018 Nov 27;6(1):211
pubmed: 30482240
ISME J. 2017 Dec;11(12):2864-2868
pubmed: 28742071
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Antimicrob Agents Chemother. 2006 Dec;50(12):4030-7
pubmed: 17030564
Microbiome. 2018 Feb 13;6(1):34
pubmed: 29439741
PLoS One. 2017 Feb 21;12(2):e0171642
pubmed: 28222110
Vet Anim Sci. 2016 Aug 12;1-2:9-14
pubmed: 32734018
New Microbes New Infect. 2015 Apr 16;6:22-9
pubmed: 26029375
Genome Res. 2017 May;27(5):824-834
pubmed: 28298430
ISME J. 2021 Jan;15(1):270-281
pubmed: 32963346
Clin Infect Dis. 2007 Apr 1;44(7):977-80
pubmed: 17342653
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Foodborne Pathog Dis. 2016 Jan;13(1):36-9
pubmed: 26575358
Environ Pollut. 2019 Feb;245:398-407
pubmed: 30453138
Poult Sci. 2007 Nov;86(11):2466-71
pubmed: 17954599
Poult Sci. 2019 Apr 1;98(4):1791-1804
pubmed: 30544256
Foodborne Pathog Dis. 2013 Nov;10(11):916-32
pubmed: 23962019
J Membr Biol. 2018 Feb;251(1):15-33
pubmed: 29063140
Genome Res. 2015 Jul;25(7):1043-55
pubmed: 25977477
J Antimicrob Chemother. 2003 Aug;52(2):159-61
pubmed: 12837737
Global Health. 2013 Oct 16;9:48
pubmed: 24131666
Appl Environ Microbiol. 2003 Aug;69(8):4343-51
pubmed: 12902214
Nat Methods. 2015 Jan;12(1):59-60
pubmed: 25402007
Emerg Infect Dis. 1999 Sep-Oct;5(5):607-25
pubmed: 10511517
PLoS One. 2019 Mar 6;14(3):e0212446
pubmed: 30840648
Nat Commun. 2019 Sep 27;10(1):4406
pubmed: 31562300
Clin Microbiol Rev. 2018 Sep 12;31(4):
pubmed: 30209034
PLoS One. 2015 May 21;10(5):e0128122
pubmed: 25996930
Microb Drug Resist. 2020 Oct;26(10):1163-1173
pubmed: 32379525
mSphere. 2019 Jul 3;4(4):
pubmed: 31270174
BMC Bioinformatics. 2010 Mar 08;11:119
pubmed: 20211023
Foodborne Pathog Dis. 2013 Apr;10(4):331-7
pubmed: 23461609
Genomics. 2010 Jun;95(6):315-27
pubmed: 20211242
Bioinformatics. 2019 Nov 15;:
pubmed: 31730192
PLoS One. 2018 Feb 14;13(2):e0192450
pubmed: 29444134
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S25-34
pubmed: 16323116
Nat Biotechnol. 2017 Aug 8;35(8):725-731
pubmed: 28787424
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
J Gen Appl Microbiol. 2003 Feb;49(1):29-36
pubmed: 12682864